Articles on Esketamine

Displaying all articles

A group of international experts has undertaken a critique of the clinical trials conducted to date on the value of hallucinogens in treating psychiatric disorders. Milad Fakurian/Unsplash

Hallucinogens approved for treating psychiatric disorders: what does the science say?

MDMA, psilocybin, ketamine derivatives, and other hallucinogens are authorised in certain countries to treat depression or post-traumatic stress disorder. What is the level of evidence?

Top contributors

More